Raymond James Financial
PDSB icon

Raymond James Financial’s PDS Biotechnology PDSB Stock Holding History

Raymond James Financial’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8K Buy
33,819
+23,583
+230% +$25K ﹤0.01% 5307
2026
Q1 		$6.19K Sell
10,236
-3,500
-25% -$2.63K ﹤0.01% 5268
2025
Q4 		$10.6K Sell
13,736
-40
-0.3% -$36 ﹤0.01% 5136
2025
Q3 		$13.9K Sell
13,776
-89
-0.6% -$105 ﹤0.01% 4922
2025
Q2 		$18.4K Sell
13,865
-100
-0.7% -$136 ﹤0.01% 5633
2025
Q1 		$16.6K Sell
13,965
-1,900
-12% -$2.7K ﹤0.01% 4733
2024
Q4 		$25.9K Buy
+15,865
New +$42K ﹤0.01% 4693

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Raymond James Financial's PDSB Position: Q2 2026 in Review

Raymond James Financial increased its PDS Biotechnology (PDSB) stake by 230% in Q2 2026, buying an estimated $25K and bringing the position to 33,819 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5307.

Raymond James Financial first reported a position in PDSB in Q4 2024 and has held it in 7 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Raymond James Financial held 33,819 shares of PDS Biotechnology worth $29.8K as of Q2 2026.
  • Raymond James Financial bought 23,583 PDS Biotechnology shares in Q2 2026, an estimated $25K.
  • PDS Biotechnology made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5307 holding.
  • Raymond James Financial first reported a position in PDS Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.